Can-Fite BioPharma Ltd.
CANF- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001536196
No open-market purchases or sales by Can-Fite BioPharma Ltd. insiders were filed in the last 90 days; 8 institutions reported holding it in 13F filings for Q2 2026, worth $149.1K in total; no superinvestor holds it.
Q3 2024 vs. Q2 2024
How the institutions holding Can-Fite BioPharma Ltd. changed between Q2 2024 and Q3 2024.
All holders in Q3 2024All holders in Q2 2024
| Measure | Q2 2024 | Q3 2024 | Change |
|---|---|---|---|
| Holders | 11 | 12 | +1 |
| Shares | 627.8K | 754.3K | +126.5K (+20.2%) |
| Value | $1.62M | $1.52M | −$103.1K (−6.4%) |
New holders (3)
Institutions that held Can-Fite BioPharma Ltd. at the end of Q3 2024 but not at the end of Q2 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Two Sigma Securities, LLC | 29,570 | $59.4K | 0.00% |
| Wells Fargo & Company | 2,500 | $5.03K | 0.00% |
| Avion Wealth | 100 | $0 | 0.00% |
Sold out (2)
Institutions that held Can-Fite BioPharma Ltd. at the end of Q2 2024 and filed for Q3 2024 without it.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| HRT Financial LP | 10,790 | $27.0K |
| Virtu Financial LLC | 10,417 | $27.0K |